NeuroAge Therapeutics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $250K

  • Investors
  • 8

NeuroAge Therapeutics General Information

Description

Operator of a biotech platform intended to assess and reverse brain aging, helping reduce the risk of neurodegenerative diseases like Alzheimer's and Parkinson's. The company's platform offers AI-powered cognitive testing, genetic analysis, blood biomarkers, MRI assessments, longitudinal tracking of brain health, and detailed reports on memory, attention, and problem-solving, along with personalized lifestyle, nutrition, and therapeutic recommendations, enabling individuals concerned with brain health to understand their brain aging and receive tailored guidance to slow cognitive decline.

Contact Information

Website
www.neuroagetx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 135 Mississippi Street
  • San Francisco, CA 94107
  • United States
Primary Industry
Laboratory Services (Healthcare)
Vertical(s)
AudioTech, LOHAS & Wellness, Artificial Intelligence & Machine Learning, Life Sciences
Corporate Office
  • 135 Mississippi Street
  • San Francisco, CA 94107
  • United States

NeuroAge Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuroAge Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 01-Feb-2024 $250K Completed Generating Revenue
3. Accelerator/Incubator 01-Nov-2023 Completed Generating Revenue
2. Seed Round 30-Oct-2023 Completed Startup
1. Grant 01-Jan-2023 $60K Completed Startup
To view NeuroAge Therapeutics’s complete valuation and funding history, request access »

NeuroAge Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotech platform intended to assess and reverse brain aging, helping reduce the risk of neurodegenerative
Laboratory Services (Healthcare)
San Francisco, CA
7 As of 2025

San Francisco, CA
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NeuroAge Therapeutics Competitors (8)

One of NeuroAge Therapeutics’s 8 competitors is Verge Labs, a Venture Capital-Backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Verge Labs Venture Capital-Backed San Francisco, CA
Junevity Venture Capital-Backed San Francisco, CA
Fauna Bio Venture Capital-Backed Emeryville, CA
Juvena Therapeutics Venture Capital-Backed Redwood City, CA
Fountain Therapeutics Venture Capital-Backed San Francisco, CA
You’re viewing 5 of 8 competitors. Get the full list »

NeuroAge Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NeuroAge Therapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alzheimers Drug Discovery Foundation Not-For-Profit Venture Capital
Berkeley SkyDeck Accelerator/Incubator Minority
Arben Ventures Venture Capital Minority
Berkeley SkyDeck Fund Venture Capital Minority
Black Mountain Ventures Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

NeuroAge Therapeutics FAQs

  • When was NeuroAge Therapeutics founded?

    NeuroAge Therapeutics was founded in 2022.

  • Where is NeuroAge Therapeutics headquartered?

    NeuroAge Therapeutics is headquartered in San Francisco, CA.

  • What is the size of NeuroAge Therapeutics?

    NeuroAge Therapeutics has 7 total employees.

  • What industry is NeuroAge Therapeutics in?

    NeuroAge Therapeutics’s primary industry is Laboratory Services (Healthcare).

  • Is NeuroAge Therapeutics a private or public company?

    NeuroAge Therapeutics is a Private company.

  • What is NeuroAge Therapeutics’s current revenue?

    The current revenue for NeuroAge Therapeutics is .

  • How much funding has NeuroAge Therapeutics raised over time?

    NeuroAge Therapeutics has raised $200K.

  • Who are NeuroAge Therapeutics’s investors?

    Alzheimers Drug Discovery Foundation, Berkeley SkyDeck, Arben Ventures, Berkeley SkyDeck Fund, and Black Mountain Ventures are 5 of 8 investors who have invested in NeuroAge Therapeutics.

  • Who are NeuroAge Therapeutics’s competitors?

    Verge Labs, Junevity, Fauna Bio, Juvena Therapeutics, and Fountain Therapeutics are some of the 8 competitors of NeuroAge Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process